Signal Advisors Wealth’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
Signal Advisors Wealth's HCAT Position: Q1 2026 in Review
Signal Advisors Wealth reduced its Health Catalyst (HCAT) stake by 37% in Q1 2026, selling an estimated $26.2K and leaving 23,293 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #570.
Signal Advisors Wealth first reported a position in HCAT in Q2 2025 and has held it in 4 quarters since. The position peaked at $645K in Q2 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- Signal Advisors Wealth held 23,293 shares of Health Catalyst worth $29.6K as of Q1 2026.
- Signal Advisors Wealth sold 13,912 Health Catalyst shares in Q1 2026, an estimated $26.2K.
- Health Catalyst made up ﹤0.01% of Signal Advisors Wealth's portfolio in Q1 2026, its #570 holding.
- Signal Advisors Wealth first reported a position in Health Catalyst in Q2 2025 and has held it in 4 quarters since.
- Signal Advisors Wealth's Health Catalyst position peaked at $645K in Q2 2025.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on Signal Advisors Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.